nalidixic acid has been researched along with Xeroderma Pigmentosum in 2 studies
Xeroderma Pigmentosum: A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mattern, MR | 1 |
| Scudiero, DA | 1 |
| Thielmann, HW | 1 |
| Popanda, O | 1 |
| Edler, L | 1 |
2 other studies available for nalidixic acid and Xeroderma Pigmentosum
| Article | Year |
|---|---|
Dependence of mammalian DNA synthesis on DNA supercoiling. III. Characterization of the inhibition of replicative and repair-type DNA synthesis by novobiocin and nalidixic acid.
Topics: Cell Line; Cell Survival; DNA; DNA Repair; DNA Replication; DNA Topoisomerases, Type I; DNA, Superhe | 1981 |
The effects of inhibitors of topoisomerase II and quinacrine on ultraviolet-light-induced DNA incision in normal and xeroderma pigmentosum fibroblasts.
Topics: Aminocoumarins; Cell Cycle; Cells, Cultured; Coumarins; DNA; DNA Damage; DNA Repair; DNA Topoisomera | 1991 |